CA2079454A1 - Steroid 5.alpha.-reductases - Google Patents
Steroid 5.alpha.-reductasesInfo
- Publication number
- CA2079454A1 CA2079454A1 CA002079454A CA2079454A CA2079454A1 CA 2079454 A1 CA2079454 A1 CA 2079454A1 CA 002079454 A CA002079454 A CA 002079454A CA 2079454 A CA2079454 A CA 2079454A CA 2079454 A1 CA2079454 A1 CA 2079454A1
- Authority
- CA
- Canada
- Prior art keywords
- preparation
- reductases
- alpha
- steroid
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003431 steroids Chemical class 0.000 title abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000009088 enzymatic function Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/01—Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
- C12Y103/01022—3-Oxo-5alpha-steroid 4-dehydrogenase (NADP+) (1.3.1.22), i.e. cortisone alpha-reductase
Abstract
Disclosed are methods and compositions for the preparation of human steroid 5.alpha.-reductases by recombinant means, as well as for the use of these enzymes in screening assays for the identification of compounds which have the ability to inhibit or otherwise alter the enzymatic function of these enzymes. In particular embodiments, methods and compositions are disclosed for the preparation of steroid 5.alpha.-reductases from human sources, as well as DNA sequences which encode these enzymes. These se-quences may be used directly in the preparation of genetic constructs, or may be employed in the preparation of hybridization probes for the selection of enzyme-encoding sequences from other sources.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51766190A | 1990-04-30 | 1990-04-30 | |
US517,661 | 1990-04-30 | ||
PCT/US1991/002866 WO1991017251A1 (en) | 1990-04-30 | 1991-04-25 | STEROID 5α-REDUCTASES |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2079454A1 true CA2079454A1 (en) | 1991-10-31 |
CA2079454C CA2079454C (en) | 2002-02-26 |
Family
ID=24060703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002079454A Expired - Fee Related CA2079454C (en) | 1990-04-30 | 1991-04-25 | Steroid 5.alpha.-reductases |
Country Status (8)
Country | Link |
---|---|
US (2) | US5422262A (en) |
EP (1) | EP0528906B1 (en) |
JP (1) | JP3294844B2 (en) |
AT (1) | ATE129013T1 (en) |
AU (1) | AU642501B2 (en) |
CA (1) | CA2079454C (en) |
DE (1) | DE69113795T2 (en) |
WO (1) | WO1991017251A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU642501B2 (en) * | 1990-04-30 | 1993-10-21 | Board Of Regents, The University Of Texas System | Steroid 5alpha-reductases |
US5576191A (en) * | 1994-06-17 | 1996-11-19 | Immunex Corporation | Cytokine that binds ST2 |
US5656613A (en) * | 1995-01-04 | 1997-08-12 | Merck & Co., Inc. | Treatment of hyperandrogenic conditions |
US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
US6359194B1 (en) * | 1995-02-10 | 2002-03-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
US20020170077A1 (en) * | 1995-02-10 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
IT1276662B1 (en) * | 1995-04-04 | 1997-11-03 | Uni Degli Studi Camerino | POLYNUCLEOTIDIC VACCINES |
WO1997020930A1 (en) * | 1995-12-07 | 1997-06-12 | Baylor College Of Medicine | Urogenital sinus derived growth factor nucleotide and amino acid sequences |
EP0904277A4 (en) | 1996-02-16 | 2003-01-22 | Millennium Pharm Inc | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
WO1997038728A1 (en) * | 1996-04-15 | 1997-10-23 | Dyad Pharmaceutical Corporation | Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil |
US6143950A (en) * | 1996-04-18 | 2000-11-07 | The Salk Institute For Biological Studies | Plant steroid 5α reductase, DET2 |
ATE301674T1 (en) * | 1996-05-15 | 2005-08-15 | Altana Pharma Ag | METHOD FOR THE SEPARATION AND DETERMINATION OF HYDROPHOBIC PROTEINS BY THIN LAYER CHROMATOGRAPHY |
WO1999037986A2 (en) | 1998-01-23 | 1999-07-29 | University Of Southern California | Androgen-metabolic gene mutations and prostate cancer risk |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
WO2001079504A1 (en) * | 2000-04-13 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | 23155 NOVEL PROTEIN HUMAN 5-α REDUCTASES AND USES THEREFOR |
US20020177566A1 (en) * | 2000-04-25 | 2002-11-28 | David Pritchard | Nucleic acid sequences associated with baldness |
US6469150B1 (en) * | 2000-05-22 | 2002-10-22 | Pharmacopeia, Inc. | Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species |
EP1352054A2 (en) | 2000-10-30 | 2003-10-15 | Pharmacia Corporation | Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase |
IL155691A0 (en) * | 2000-11-09 | 2003-11-23 | Astrazeneca Ab | Oral pharmaceutical composition containing a block copolymer |
JP2002236307A (en) * | 2001-02-09 | 2002-08-23 | Asahi Optical Co Ltd | Zoom stroboscopic device |
US7635598B2 (en) * | 2004-07-08 | 2009-12-22 | Biosearch Technologies, Inc. | Inducible fluorescence assay |
US20070036740A1 (en) * | 2004-10-06 | 2007-02-15 | Reed Kenneth C | Modulation of hair growth |
EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
EP1945240B1 (en) | 2005-09-16 | 2016-12-28 | Raptor Pharmaceutical Inc | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
FR2903999B1 (en) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | MODULATORS OF SC4MOL IN THE TREATMENT OF ACNE OR HYPERSEBORRHEA |
EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
US20120156138A1 (en) * | 2009-04-14 | 2012-06-21 | Smith Larry J | Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming |
SG10201402069PA (en) | 2009-05-06 | 2014-07-30 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU642501B2 (en) * | 1990-04-30 | 1993-10-21 | Board Of Regents, The University Of Texas System | Steroid 5alpha-reductases |
-
1991
- 1991-04-25 AU AU78579/91A patent/AU642501B2/en not_active Ceased
- 1991-04-25 EP EP91909339A patent/EP0528906B1/en not_active Expired - Lifetime
- 1991-04-25 CA CA002079454A patent/CA2079454C/en not_active Expired - Fee Related
- 1991-04-25 AT AT91909339T patent/ATE129013T1/en not_active IP Right Cessation
- 1991-04-25 WO PCT/US1991/002866 patent/WO1991017251A1/en active IP Right Grant
- 1991-04-25 DE DE69113795T patent/DE69113795T2/en not_active Expired - Fee Related
- 1991-04-25 JP JP50901491A patent/JP3294844B2/en not_active Expired - Fee Related
- 1991-11-18 US US07/795,859 patent/US5422262A/en not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/457,616 patent/US5679521A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU642501B2 (en) | 1993-10-21 |
DE69113795T2 (en) | 1996-03-28 |
EP0528906A1 (en) | 1993-03-03 |
JPH05507405A (en) | 1993-10-28 |
US5422262A (en) | 1995-06-06 |
CA2079454C (en) | 2002-02-26 |
ATE129013T1 (en) | 1995-10-15 |
JP3294844B2 (en) | 2002-06-24 |
DE69113795D1 (en) | 1995-11-16 |
US5679521A (en) | 1997-10-21 |
AU7857991A (en) | 1991-11-27 |
EP0528906B1 (en) | 1995-10-11 |
WO1991017251A1 (en) | 1991-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2079454A1 (en) | Steroid 5.alpha.-reductases | |
CA2190588A1 (en) | Pteridine nucleotide analogs as fluorescent dna probes | |
AU6589094A (en) | 7-deazapurine modified oligonucleotides | |
AU3246300A (en) | Polypeptides having galactose oxidase activity and nucleic acids encoding same | |
CA2294516A1 (en) | Ikk-.beta. proteins, nucleic acids and methods | |
EP1408122A3 (en) | Methods and compositions for efficient nucleic acid sequencing | |
CA2000786A1 (en) | 3-piperidinyl-1,2-benzisoxazoles | |
CA2123354A1 (en) | Thermostable nucleic acid polymerase | |
EP1700915A3 (en) | Enzymatic DNA molecules | |
CA2217668A1 (en) | Genetic markers for breast and ovarian cancer | |
CA2295999A1 (en) | Nik proteins, nucleic acids and methods | |
CA2295306A1 (en) | Dna polymerase-related factors | |
AU3025597A (en) | Method of providing novel dna sequences | |
WO1998026093A3 (en) | Fluorescent nucleotide analog hairpin formation for detection of nucleic acid hybridization | |
CA2281895A1 (en) | Ikb kinases | |
CA2263713A1 (en) | Lyophilization of cultured human cells to preserve rna and dna | |
DE69808743D1 (en) | Netrinrezeptoren | |
CA2170515A1 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
CA2294566A1 (en) | Ikk-.alpha. proteins, nucleic acids and methods | |
CA2294476A1 (en) | Semaphorin receptors | |
AU614489B2 (en) | Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells | |
WO1997027276A3 (en) | Nucleic acids encoding polypeptides having absidia lipase activity | |
CA2112096A1 (en) | Dna sequences of the human papillomavirus type 42 and diagnostic application thereof | |
WO1999047558A3 (en) | T cell costimulatory proteins, sequences and uses thereof | |
GB8929293D0 (en) | C.difficile dna probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |